What’s New in Liver Cancer Research? Track 23 Explores the Next Frontier
What’s New in Liver Cancer Research? Track 23 Explores the Next Frontier Introduction Liver cancer remains one of the world’s most formidable cancer challenges. Among liver malignancies, Hepatocellular carcinoma (HCC) stands out — accounting for the majority of primary liver cancers — and its high mortality largely stems from late-stage diagnosis and limited treatment options. However, thanks to advances in diagnostics, molecular biology, computational methods, immunotherapy, and interventional techniques, the landscape of liver cancer research is rapidly evolving. In anticipation of the upcoming conference, 12th International Cancer, Oncology & Therapy Conference , and specifically Track 23: Liver Cancer , it’s a fitting time to survey the cutting-edge developments shaping the future of liver-cancer care. Let’s explore what’s new — from early detection and molecular insights to novel therapies and AI-guided interventions. (If you’d like, I can also include a sectio...